Buserelin
Reproductive & endocrine
Early humanHistorical human research spans IVF protocols, endometriosis, hormone sensitive oncology, and pediatric endocrinology.
Limited, exploratory, early phase or small human studies have been identified.
What is Buserelin?
Buserelin is a synthetic GnRH agonist peptide historically employed in reproductive endocrinology research, including IVF, endometriosis and paediatric endocrinology studies; the catalogue item denotes research grade buserelin.
Which research context has Buserelin been associated with?
Buserelin is associated with historical human reproductive endocrine research spanning IVF protocols, endometriosis, hormone sensitive oncology and paediatric endocrinology, used as a GnRH agonist probe in clinical investigation.
What documentation is available for Buserelin?
Buserelin: Batch documents are not yet linked on this site. Documentation for this synthetic GnRH agonist peptide should include batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content, counterion and residual solvent/water details; and validated potency/assay for release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Buserelin?
Buserelin: Storage depends on the documented supplied presentation; as a synthetic GnRH agonist peptide verify whether supplied dry/lyophilised or in solution, counterion and concentration, solvent or buffer composition, pH sensitivity, container closure compatibility and freeze/thaw behaviour that influence degradation and aggregation. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.